SARS-CoV-2 Vaccination in Adolescent Solid Organ Transplant Recipients

By Victoria Socha

Results of previous analyses have demonstrated that adolescent solid organ transplant recipients who receive three doses of SARS-CoV-2 mRNA vaccine experience high seroconversion rates and antibody persistence for up to 3 months. There are few data available on the long-term antibody durability in that patient population. Read the article in DocWire News.